ScholarGate
Asystent

Porównaj metody

Przeglądaj wybrane metody obok siebie; wiersze, które się różnią, są wyróżnione.

Kryteria diagnostyczne zespołu jelita drażliwego według IV Kryteriów Rzymskich×Skrócony Kwestionariusz Chorób Zapalnych Jelit×
DziedzinaGastroenterologiaGastroenterologia
RodzinaProcess / pipelineProcess / pipeline
Rok powstania20162004
TwórcaRome Foundation (multinational expert consensus)Guyonnet, D., Chassany, O., Ducroc, R., et al.
TypDiagnostic CriteriaSelf-report
Źródło pierwotneMearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation. link ↗Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465. link ↗
Inne nazwyRome IV IBS, Rome CriteriaIBDQ-32, Short IBDQ
Pokrewne44
PodsumowanieThe Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.
ScholarGateZbiór danych
  1. v1
  2. 1 Źródła
  3. PUBLISHED
  1. v1
  2. 1 Źródła
  3. PUBLISHED

Przejdź do wyszukiwania Pobierz slajdy

ScholarGatePorównaj metody: Rome IV Irritable Bowel Syndrome Criteria · Short Inflammatory Bowel Disease Questionnaire. Pobrano 2026-06-20 z https://scholargate.app/pl/compare